253 related articles for article (PubMed ID: 26733478)
1. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
[TBL] [Abstract][Full Text] [Related]
2. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes.
Herder C; Fürstos JF; Nowotny B; Begun A; Strassburger K; Müssig K; Szendroedi J; Icks A; Roden M;
Brain Behav Immun; 2017 Mar; 61():137-145. PubMed ID: 28041985
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes.
Herder C; Schamarek I; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Kannenberg JM; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
Heart; 2017 Jan; 103(1):63-70. PubMed ID: 27481890
[TBL] [Abstract][Full Text] [Related]
4. Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.
Akarsu E; Pirim I; Capoğlu I; Deniz O; Akçay G; Unüvar N
Diabetes Care; 2001 Jan; 24(1):100-3. PubMed ID: 11194212
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
[TBL] [Abstract][Full Text] [Related]
6. Associations of cells from both innate and adaptive immunity with lower nerve conduction velocity: the Maastricht Study.
Maalmi H; Wouters K; Savelberg HHCM; van der Velde JHPM; Reulen JPH; Mess W; Schalkwijk CG; Stehouwer CDA; Roden M; Ziegler D; Herder C; Schaper NC
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431599
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.
Hansen CS; Vistisen D; Jørgensen ME; Witte DR; Brunner EJ; Tabák AG; Kivimäki M; Roden M; Malik M; Herder C
Cardiovasc Diabetol; 2017 Dec; 16(1):153. PubMed ID: 29195493
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
[TBL] [Abstract][Full Text] [Related]
9. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
[TBL] [Abstract][Full Text] [Related]
10. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
Tkac I; Bril V
Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
[TBL] [Abstract][Full Text] [Related]
12. The role of blink reflex R1 latency as an electrophysiological marker in diabetic distal symmetrical polyneuropathy.
Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
Clin Neurophysiol; 2020 Jan; 131(1):34-39. PubMed ID: 31751837
[TBL] [Abstract][Full Text] [Related]
13. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
Jarmuzewska EA; Mangoni AA
J Intern Med; 2005 Jul; 258(1):38-44. PubMed ID: 15953131
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes.
Lai YR; Chiu WC; Huang CC; Cheng BC; Kung CT; Lin TY; Chiang HC; Tsai CJ; Kung CF; Lu CH
Neurophysiol Clin; 2024 Jul; 54(4):102982. PubMed ID: 38761793
[TBL] [Abstract][Full Text] [Related]
16. Time-course changes in nerve conduction velocity (NCV) in type 2 diabetes.
Morimoto J; Suzuki Y; Tada A; Akui M; Ozawa Y; Maruyama T
J Diabetes Complications; 2012; 26(3):237-40. PubMed ID: 22502938
[TBL] [Abstract][Full Text] [Related]
17. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
Bril V; Hirose T; Tomioka S; Buchanan R;
Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
[TBL] [Abstract][Full Text] [Related]
18. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study.
Herder C; Bongaerts BW; Rathmann W; Heier M; Kowall B; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2013 Nov; 36(11):3663-70. PubMed ID: 24009302
[TBL] [Abstract][Full Text] [Related]
19. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
[TBL] [Abstract][Full Text] [Related]
20. Correlations among autonomic, sensory, and motor neural function tests in untreated non-insulin-dependent diabetic individuals.
Pfeifer MA; Weinberg CR; Cook DL; Reenan A; Halar E; Halter JB; LaCava EC; Porte D
Diabetes Care; 1985; 8(6):576-84. PubMed ID: 4075943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
